9 Rheumatoid Arthritis Clinical Trials in Charleston, WV (2026)

Q: How do I join a clinical trial in Charleston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Charleston research site will contact you.

Recruiting Rheumatoid Arthritis Studies in Charleston

NCT07280065Recruiting

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

The goal of the REVEAL PTSD study is to test how well the Senseye DT works as a diagnostic test for Post-traumatic Stress Disorder (PTSD) in adults 18 and older who are experiencing one or more sympto...

Charleston, WV1,900 participantsSenseye, Inc.

View Study Details

NCT05762302Recruiting

The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

This is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to d...

Charleston, WV1,316 participantsMeMed Diagnostics Ltd.

View Study Details

NCT06957067Recruiting

Reducing Dropout and Improving Outcomes From PTSD Therapy: When to Switch Therapies or Stay the Course

Investigators' overall objective is to compare methods of identifying individuals who may be experiencing challenges in Cognitive Processing Therapy (CPT) and compare methods of intervening to optimiz...

Charleston, WV280 participantsUnited States Department of Defense

View Study Details

NCT06442566Recruiting

ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain

This study will sequentially evaluate three novel and scalable interventions for at-risk individuals on long term opioid therapy for chronic pain: (1) low-dose transdermal buprenorphine initiation wit...

Charleston, WV240 participantsMedical University of South Carolina

View Study Details

NCT07227064Recruiting

Methadone in THA for Post-op Pain and Opioid Reduction

This randomized, double-blind controlled trial investigates whether intraoperative intravenous methadone (0.15 mg/kg based on ideal body weight) reduces acute postoperative pain and opioid consumption...

Charleston, WV162 participantsMedical University of South Carolina

View Study Details

NCT05191706Recruiting

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCUfor the Treatment of Inflammation Following Ocular Surgery for Chi...

Charleston, WV60 participantsEyePoint Pharmaceuticals, Inc.

View Study Details

NCT06960096Recruiting

Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study

The objective of this research study is to understand how Deep Brain Stimulation (DBS) targeting the subthalamic nucleus (STN) affects cognitive networks in the brain, potentially leading to cognitive...

Charleston, WV55 participantsMedical University of South Carolina

View Study Details

NCT06743425Recruiting

A Pilot Study of a Remote ADHD Monitoring Program

RAMP is a pilot study examining the use of an Attention-Deficit/Hyperactivity Disorder (ADHD) Monitoring Program during the early stages of treating ADHD in children living in rural settings. This tri...

Charleston, WV36 participantsIDeA States Pediatric Clinical Trials Network

View Study Details

NCT04029337Recruiting

An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System

Study to evaluate the feasibility, safety and performance of the HighLife trans-septal Transcatheter Mitral Valve in patients with moderate-severe and severe mitral regurgitation who are at high risk ...

Charleston, WV30 participantsHighLife SAS

View Study Details

About Rheumatoid Arthritis Clinical Trials in Charleston

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 9 rheumatoid arthritis clinical trials recruiting participants in Charleston, WV. These studies are seeking a combined 4,079 participants. Research is being sponsored by Senseye, Inc., MeMed Diagnostics Ltd., United States Department of Defense and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Rheumatoid Arthritis Clinical Trials in Charleston — FAQ

Are there rheumatoid arthritis clinical trials in Charleston?

Yes, there are 9 rheumatoid arthritis clinical trials currently recruiting in Charleston, WV. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charleston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charleston research site will contact you about next steps.

Are clinical trials in Charleston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charleston studies also compensate for your time and travel.

What rheumatoid arthritis treatments are being tested?

The 9 active trials in Charleston are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.

Data updated July 13, 2026 from ClinicalTrials.gov